Braveheart Bio
BRVE · NASDAQ
$21.44−$0.04 (−0.19%)TodayMarket closed ·
Prev close $21.48
Who owns BRVE
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 76.0% of BRVE’s shares.
- Forbion Growth Opportunities Fund III Cooperatief UA23.7%
- OrbiMed Advisors, LLC13.5%
- AH Bio Fund IV LP11.4%
- Murdoch (Travis)9.3%
- Next 6 largest institutions18.2%
- All other shareholders24.0%
| Holder | Shares | % of shares |
|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief UA | 21.31M | 23.67% |
| OrbiMed Advisors, LLC | 12.18M | 13.52% |
| AH Bio Fund IV LP | 10.23M | 11.36% |
| Murdoch (Travis) | 8.33M | 9.26% |
| Jiangsu Hengrui Pharmaceuticals Co. Ltd. | 7.42M | 8.24% |
| Frazier Healthcare Partners | 4.98M | 5.53% |
| Forbion Growth Opportunities Fund I Cooperatief UA | 1.10M | 1.22% |
| Coloma (Jason V Ph.D.) | 1.10M | 1.22% |
| Malek (David I) | 1.01M | 1.13% |
| Viehbacher (Christopher) | 759.86K | 0.84% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Disruptive Medicine ETF | 11.80K | 0.01% |
| T. Rowe Price Health Care ETF | 3.60K | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $159.03M (13 trades) of BRVE on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| ORBIMED ADVISORS LLC | Other | 40.00M | — |
| ORBIMED ADVISORS LLC | Buy | 273.33K | $4.92M |
| ORBIMED ADVISORS LLC | Buy | 1.67M | $30.00M |
| ORBIMED ADVISORS LLC | Other | 9.13M | — |
| Malek David I | Buy | 4.17K | $74.99K |
| Anderson Michele A. | Buy | 1.11K | $20.00K |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Other | 32.50M | — |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Other | 7.42M | — |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Other | 35.00M | — |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Other | 40.00M | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.13M
- Days to cover
- 5.10
- % of shares outstanding
- 4.59%
- Average daily volume
- 809.95K
- Change since last report
- +67.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.